| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/13/2008 | CN100410252C Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 08/13/2008 | CN100410251C Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410249C 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
| 08/12/2008 | US7411073 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411070 Form of S-omeprazole |
| 08/12/2008 | US7411067 Crystalline forms of gatifloxacin |
| 08/12/2008 | US7411053 Containing substituted or unsubstituted bipyridine, tripyridine, or phenanthroline groups, e.g., Di-[p-(2,2':6',2'')terpyridin-4'-ylbenzyl] 4,4'-azobis(4-cyanovalerate) and N,N'-di-[1,10-phenanthrolin-5-yl]-4,4'-azobis(4-cyanovalerylamide); RAFT polymerization catalysts |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410992 Ophthalmic compositions for treating ocular hypertension |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410977 Fluorinated 4-azasteroids as androgen receptor modulators |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/12/2008 | CA2308660C Stable aqueous pharmaceutical composition comprising tezosentan |
| 08/07/2008 | WO2008094992A2 2-aminopyridine derivatives useful as kinase inhibitors |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008094896A1 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors |
| 08/07/2008 | WO2008094690A2 Methods for preparing eszopiclone |
| 08/07/2008 | WO2008093960A1 Novel dipeptidyl peptidase-iv inhibitors |
| 08/07/2008 | WO2008093940A1 Quinoline derivatives as caspase-3 inhibitor, preparation process for the same and pharmaceutical composition comprising the same |
| 08/07/2008 | WO2008093920A2 1,2-dihydro-1-oxophthalazinyl derivatives having biological activity on serotonin receptors 5-ht2a and 5-ht2c, and preparation thereof |
| 08/07/2008 | WO2008093838A1 Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof |
| 08/07/2008 | WO2008093639A1 Pyrazole compound |
| 08/07/2008 | WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| 08/07/2008 | WO2008092942A2 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators |
| 08/07/2008 | WO2008092352A1 Antitumor compounds and their preparation method |
| 08/07/2008 | WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 08/07/2008 | WO2008059029A3 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188666 Stereoisomers with improved selectivity towards the glucocorticoid receptor; treatment of inflammatory diseases such as chronic obstructive pulmonary disease (COPD), asthma or allergic rhinitis; 4-aryl-1-{[1-(aryl)indazol-4-yl]amino}-2-(trifluoromethyl)pentan-2-ol compounds or corresponding amide |
| 08/07/2008 | US20080188658 Novel synthesis of gatifloxacin |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188527 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
| 08/07/2008 | US20080188521 Novel pharmaceutical compounds |
| 08/07/2008 | US20080188520 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; potassium channel KACh and TASK-1 channel blocking agent; atrial arrhythmias, atrial fibrillation or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent |
| 08/07/2008 | US20080188503 New Compounds II |
| 08/07/2008 | US20080188502 New Compounds I |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188491 Modulation of pathogenicity |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188484 Indol-2-yl-piperazin-1-yl-methanone derivatives |
| 08/07/2008 | US20080188481 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 08/07/2008 | US20080188478 Compounds Useful In Therapy |
| 08/07/2008 | US20080188474 Substituted triazoles useful as axl inhibitors |
| 08/07/2008 | US20080188473 Indoles Useful in the Treatment of Inflammation |
| 08/07/2008 | US20080188472 Indole-2-Carboxylic Acid Hydrazides |
| 08/07/2008 | US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187978 Anti-inflammatory medicaments |
| 08/07/2008 | DE60223151T2 Chinazolinonderivat Quinazolinone derivative |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2677096A1 Kinase inhibitors |
| 08/07/2008 | CA2676984A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/06/2008 | EP1953152A1 Process for preparing quinazoline RHO-kinase inhibitors and intermediates thereof |
| 08/06/2008 | EP1953151A1 Salts of cynnamide compound or solvates thereof |
| 08/06/2008 | EP1953150A1 Process for production of 2-(4-methyl-2-phenylpiperazin- 1-yl)pyridine-3-methanol |
| 08/06/2008 | EP1953148A1 Heterocyclic amide compound and use thereof |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1951715A2 Aminopyrimidines useful as kinase inhibitors |
| 08/06/2008 | EP1951708A2 Piperazine derivatives useful as ccr5 antagonists |
| 08/06/2008 | EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951705A1 Novel antifungal triazole derivatives |
| 08/06/2008 | EP1951704A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 08/06/2008 | EP1951703A2 Desloratadine crystalline forms mixtures having a low level of residual solvents |
| 08/06/2008 | EP1951690A1 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951689A1 P2x7 receptor antagonists and methods of use |
| 08/06/2008 | EP1951683A1 Pyrimidine derivatives for the treatment of cancer |
| 08/06/2008 | EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 08/06/2008 | EP1951676A2 Lxr modulators |
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1951673A2 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951669A1 Acyl indoles, compositions containing such compounds and methods of use |
| 08/06/2008 | EP1951667A2 Thrombopoietin activity modulating compounds and methods |
| 08/06/2008 | EP1951665A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 08/06/2008 | EP1907366A4 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1648882B1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 08/06/2008 | EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | CN101238135A Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 08/06/2008 | CN101238116A Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |